Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C USD Acc
XGEN.L
London Stock Exchange- -
USD
- -
- -
- -
- -
(- -)
Recent
price
- -
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C USD Acc (Ticker: XGEN.L) is an exchange-traded fund managed by Xtrackers, part of DWS Group, focusing on genomic healthcare innovation. It seeks to track the performance of the MSCI Genomic Healthcare Innovation Index, aiming to provide exposure to global equity securities of companies engaged in genomics, gene editing, precision medicine, biotech diagnostics, and related technologies. Main Products and Services: UCITS-compliant ETF products; index-tracking funds; custody and administration of UCITS vehicle; liquidity management and trading operations; risk monitoring and reporting; fund documentation and investor communications; distributions and income reinvestment options; corporate actions processing; collateral and cash management services; fund distribution across European and other global markets; ETF creation and redemption by authorized participants. Latest Major Company Changes: Expansions in product line and regional reach through inclusion in broader UCITS ETF offerings; potential fund-level amendments to tracking methodology or index rebalancing rules; strategic alignment with parent group’s global ETF platform to enhance distribution channels and liquidity; updates to fund prospectus and key investor documents reflecting regulatory changes and market developments. Additional Context: Industry and business segments include passive index-tracking investment products within the European ETF landscape; target markets comprise institutional and retail investors seeking thematic exposure to genomics and life sciences innovation; geographic operations span Europe with distributed access to global markets; founding year and headquarters: Xtrackers operates under DWS Group, with primary operations centered in Germany and Europe; subsidiaries and parent company relationships include DWS Group as the sponsor and top-level manager of the ETF vehicle.